Compare KVUE & LYV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KVUE | LYV |
|---|---|---|
| Founded | 2022 | 2005 |
| Country | United States | United States |
| Employees | 22000 | N/A |
| Industry | Specialty Chemicals | Services-Misc. Amusement & Recreation |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.6B | 36.0B |
| IPO Year | 2023 | 2005 |
| Metric | KVUE | LYV |
|---|---|---|
| Price | $17.49 | $156.60 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 21 |
| Target Price | $19.45 | ★ $182.38 |
| AVG Volume (30 Days) | ★ 15.5M | 2.8M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | ★ 4.75% | N/A |
| EPS Growth | ★ 40.74 | N/A |
| EPS | ★ 0.76 | N/A |
| Revenue | $15,124,000,000.00 | ★ $25,201,406,000.00 |
| Revenue This Year | $4.85 | $10.24 |
| Revenue Next Year | $2.63 | $9.37 |
| P/E Ratio | $23.01 | ★ N/A |
| Revenue Growth | N/A | ★ 8.83 |
| 52 Week Low | $14.02 | $125.34 |
| 52 Week High | $25.17 | $175.25 |
| Indicator | KVUE | LYV |
|---|---|---|
| Relative Strength Index (RSI) | 50.07 | 49.21 |
| Support Level | $17.20 | $151.83 |
| Resistance Level | $17.74 | $157.13 |
| Average True Range (ATR) | 0.32 | 5.44 |
| MACD | 0.04 | -0.71 |
| Stochastic Oscillator | 72.73 | 28.70 |
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.
Live Nation is the largest live entertainment company in the world, serving as a concert promoter, venue operator, and ticketing platform. In addition, the firm generates revenue from sponsorships and advertising. With offices in 51 countries, Live Nation promotes concerts globally and it owned, operated, or had exclusive booking rights to more than 400 venues worldwide at the end of 2025, which the firm says makes it the second-largest operator of music venues globally. In 2025, Live Nation promoted nearly 55,000 events, drawing roughly 160 million fans. Ticketmaster is a dominant global ticketing service, selling nearly 650 million tickets in 2025.